<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01644760</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2012/LM-01</org_study_id>
    <secondary_id>2012-A00625-38</secondary_id>
    <nct_id>NCT01644760</nct_id>
  </id_info>
  <brief_title>Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation</brief_title>
  <official_title>Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation: A Physiological Study on Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to determine a threshold value of diaphragmatic excursion
      (ultrasound measures: expiration versus inspiration)that best predicts a 50% collapsibility
      of the inferior vena cava.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives of this study are:

        -  to determine a threshold value of diaphragmatic excursion (ultrasound measures:
           expiration versus inspiration)that best predicts a 40% collapsibility of the inferior
           vena cava (IVC).

        -  to determine a threshold value of diaphragmatic excursion (ultrasound measures:
           expiration versus inspiration)that best predicts a 100% collapsibility of the IVC.

        -  to determine the location of the cutting plane for the TM analysis of collapsibility of
           the IVC.

        -  to evaluate the hemodynamic conditions of normal healthy volunteers.

        -  to detect any abnormality of cardiac function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Collapsibility score for the IVC diameter</measure>
    <time_frame>Baseline (Day 0; cross-sectional study)</time_frame>
    <description>percentage = ((max-min)/average)*100%
Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is &gt;= 50%; and (3) a measure of the diaphragmatic excursion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Collapsibility score for the IVC diameter &gt;= 50% (presence/absence)</measure>
    <time_frame>Baseline (Day 0; cross-sectional study)</time_frame>
    <description>percentage = ((max-min)/average)*100%
Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is &gt;= 50%; and (3) a measure of the diaphragmatic excursion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diaphragmatic excursion</measure>
    <time_frame>Baseline (Day 0; cross-sectional study)</time_frame>
    <description>Maximum distance between the position of the diaphragmatic dome during inspiration versus expiration (cm)
Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is &gt;= 50%; and (3) a measure of the diaphragmatic excursion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collapsibility score for the IVC diameter &gt;= 40% (presence/absence)</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
    <description>percentage = ((max-min)/average)*100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collapsibility score for the IVC diameter &gt;= 60% (presence/absence)</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
    <description>percentage = ((max-min)/average)*100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral Doppler Wave E speed</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral Doppler Wave A speed</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue Doppler Wave E' speed</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simpson: FEVG</measure>
    <time_frame>Baseline (Day 0; cross sectional study)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Collapsibility of the Inferior Vena Cava</condition>
  <arm_group>
    <arm_group_label>Study population</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy subjects with spontaneous ventilation, 18 to 50 years of age.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasounds with controlled breathing</intervention_name>
    <description>The patient will have cardiac, abdominal and thoracic ultrasounds with controlled and monitored inspiratory effort. This gesture takes about 40 minutes.</description>
    <arm_group_label>Study population</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The volunteer must have given his/her informed and signed consent

          -  The volunteer must be insured or beneficiary of a health insurance plan

        Exclusion Criteria:

          -  The volunteer is participating in another study

          -  The volunteer is in an exclusion period determined by a previous study

          -  The volunteer is under judicial protection, under tutorship or curatorship

          -  The volunteer refuses to sign the consent

          -  It is impossible to correctly inform the volunteer

          -  The patient is pregnant, parturient, or breastfeeding

          -  The volunteer has known heart disease like heart failure, cardiac arrhythmia

          -  The volunteer takes cardiotropics

          -  The volunteer has known lung disease: obstructive or restrictive respiratory failure

          -  The volunteer has clinical signs of COPD (coughing with morning sputum in a smoking
             subject)

          -  Any emergency situation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Muller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2012</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diaphragmatic excursion</keyword>
  <keyword>normality</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

